144 related articles for article (PubMed ID: 37231750)
1. Lipid Nanocapsule: A Novel Approach to Drug Delivery System Formulation Development.
Kumar P; Yadav N; Chaudhary B; Umakanthan S; Chattu VK; Kazmi I; Al-Abbasi FA; Alzarea SI; Afzal O; Altamimi ASA; Gupta G; Gupta MM
Curr Pharm Biotechnol; 2024; 25(3):268-284. PubMed ID: 37231750
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanocapsules: a new platform for nanomedicine.
Huynh NT; Passirani C; Saulnier P; Benoit JP
Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanoparticles containing babassu oil: A proposed drug delivery system for controlled release of hydrophilic compounds.
de Oliveira JVR; Silveira PL; Spingolon G; Alves GAL; Peña FP; Aguirre TAS
Chem Phys Lipids; 2023 Jul; 253():105304. PubMed ID: 37080377
[TBL] [Abstract][Full Text] [Related]
4. Evidence of residual micellar structures in a lipid nanocapsule dispersion. A multi-technique approach.
Roger E; Franconi F; Do TAT; Simonsson C; Siegler B; Perrot R; Saulnier P; Gimel JC
J Control Release; 2023 Dec; 364():700-717. PubMed ID: 37951474
[TBL] [Abstract][Full Text] [Related]
5. In vitro drug release mechanism from lipid nanocapsules (LNC).
Abdel-Mottaleb MM; Neumann D; Lamprecht A
Int J Pharm; 2010 May; 390(2):208-13. PubMed ID: 20149853
[TBL] [Abstract][Full Text] [Related]
6. Polymeric Nanocapsules as Nanotechnological Alternative for Drug Delivery System: Current Status, Challenges and Opportunities.
Deng S; Gigliobianco MR; Censi R; Di Martino P
Nanomaterials (Basel); 2020 Apr; 10(5):. PubMed ID: 32354008
[TBL] [Abstract][Full Text] [Related]
7. Polymeric lipid assemblies as novel theranostic tools.
Puri A; Blumenthal R
Acc Chem Res; 2011 Oct; 44(10):1071-9. PubMed ID: 21919465
[TBL] [Abstract][Full Text] [Related]
8. Active Encapsulation in Biocompatible Nanocapsules.
Wu B; Yang C; Li B; Feng L; Hai M; Zhao CX; Chen D; Liu K; Weitz DA
Small; 2020 Jul; 16(30):e2002716. PubMed ID: 32578400
[TBL] [Abstract][Full Text] [Related]
9. Polyoxazolines based lipid nanocapsules for topical delivery of antioxidants.
Simon L; Lapinte V; Lionnard L; Marcotte N; Morille M; Aouacheria A; Kissa K; Devoisselle JM; Bégu S
Int J Pharm; 2020 Apr; 579():119126. PubMed ID: 32070758
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
[TBL] [Abstract][Full Text] [Related]
11. Radiolabeling and targeting of lipidic nanocapsules for applications in radioimmunotherapy.
Jestin E; Mougin-Degraef M; Faivre-Chauvet A; Remaud-Le Saëc P; Hindre F; Benoit JP; Chatal JF; Barbet J; Gestin JF
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):51-60. PubMed ID: 17372573
[TBL] [Abstract][Full Text] [Related]
12. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules.
Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP
Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878
[TBL] [Abstract][Full Text] [Related]
13. Lipid nanocapsules to enhance drug bioavailability to the central nervous system.
Moura RP; Pacheco C; Pêgo AP; des Rieux A; Sarmento B
J Control Release; 2020 Jun; 322():390-400. PubMed ID: 32247807
[TBL] [Abstract][Full Text] [Related]
14. PEGylated lipid nanocapsules with improved drug encapsulation and controlled release properties.
Hervella P; Alonso-Sande M; Ledo F; Lucero ML; Alonso MJ; Garcia-Fuentes M
Curr Top Med Chem; 2014; 14(9):1115-23. PubMed ID: 24678710
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs.
Fresta M; Cavallaro G; Giammona G; Wehrli E; Puglisi G
Biomaterials; 1996 Apr; 17(8):751-8. PubMed ID: 8730958
[TBL] [Abstract][Full Text] [Related]
16. Entrance effects at nanopores of nanocapsules functionalized with poly(ethylene glycol) and their flow through nanochannels.
Popa R; Vrânceanu M; Nikolaus S; Nirschl H; Leneweit G
Langmuir; 2008 Nov; 24(22):13030-6. PubMed ID: 18950201
[TBL] [Abstract][Full Text] [Related]
17. Eco-friendly aqueous core surface-modified nanocapsules.
Carbone C; Musumeci T; Lauro MR; Puglisi G
Colloids Surf B Biointerfaces; 2015 Jan; 125():190-6. PubMed ID: 25497291
[TBL] [Abstract][Full Text] [Related]
18. Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules.
Anton N; Saulnier P; Gaillard C; Porcher E; Vrignaud S; Benoit JP
Langmuir; 2009 Oct; 25(19):11413-9. PubMed ID: 19788211
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in polymer shell oily-core nanocapsules for drug-delivery applications.
AbdElhamid AS; Zayed DG; Heikal L; Khattab SN; Mady OY; El-Gizawy SA; Elzoghby AO
Nanomedicine (Lond); 2021 Aug; 16(18):1613-1625. PubMed ID: 34189946
[TBL] [Abstract][Full Text] [Related]
20. Multilayered silica-biopolymer nanocapsules with a hydrophobic core and a hydrophilic tunable shell thickness.
Vecchione R; Luciani G; Calcagno V; Jakhmola A; Silvestri B; Guarnieri D; Belli V; Costantini A; Netti PA
Nanoscale; 2016 Apr; 8(16):8798-809. PubMed ID: 27065306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
